Akinori Takagane
Akinori Takagane publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Cancer Treatment and Pharmacology.
- World rank
- #2,574,425 of 7,710,434 ranked researchers
- Rank in Japan
- #52,898 of 383,136
- Works
- 181
- Citations
- 6.8k
- Citations per work
- 37.4
What does Akinori Takagane research?
Akinori Takagane's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13775.7%
- Medicine13775.7%
- Everything else3217.7%
- Life Sciences126.6%
- 1Oncology27% of their works
- 2Pulmonary and Respiratory Medicine26% of their works
- 3Surgery19% of their works
- 4Gastroenterology3% of their works
- 5Cancer Research3% of their works
- 6Molecular Biology3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Metastasis and carcinoma case studies
- Colorectal Cancer Surgical Treatments
- Gastrointestinal Tumor Research and Treatment
- Lung Cancer Treatments and Mutations
- Cholangiocarcinoma and Gallbladder Cancer Studies
Which keywords describe Akinori Takagane's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Endoscopic Resection, Gastric Cancer, Cetuximab, KRAS Mutations, Prognostic Factors and Surgical Management.
- Targeted Therapy
- Imatinib Mesylate
- Cholangiocarcinoma
- Rectal Cancer
- Metastatic Carcinomas
- Taxanes
- Surgical Management
- KRAS Mutations
- Gastric Cancer
- Clinical Practice Guidelines
- Chemotherapy
- Endoscopic Resection
- Cetuximab
- Prognostic Factors
- Chemotherapy-Induced Peripheral Neuropathy
- Lung Tumors
- Preoperative Chemoradiotherapy
- Biliary Tract Cancer
- EGFR Mutations
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy1562 topics
- Clinical Practice Guidelines1022 topics
- Endoscopic Resection841 topic
- Gastric Cancer841 topic
- Cetuximab721 topic
- KRAS Mutations721 topic
- Prognostic Factors342 topics
- Surgical Management342 topics
- Chemotherapy-Induced Peripheral Neuropathy261 topic
- Taxanes261 topic
- Lung Tumors201 topic
- Metastatic Carcinomas201 topic
- Preoperative Chemoradiotherapy181 topic
- Rectal Cancer181 topic
- Biliary Tract Cancer171 topic
- Cholangiocarcinoma171 topic
- EGFR Mutations171 topic
- Imatinib Mesylate171 topic
- Sunitinib171 topic
- Targeted Therapy171 topic
Where does Akinori Takagane work?
Akinori Takagane's main affiliation in the publication record is Hakodate National Hospital, Japan.
How many publications and citations does Akinori Takagane have?
OpenAlex counts 181 works and 6,766 citations for Akinori Takagane, an h-index of 33, ranking #2,574,425 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Akinori Takagane. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.